Cas:1213012-56-6 (1R)-1-(3-Fluoro-4-methylphenyl)-1-propanamine hydrochloride (1:1 ) manufacturer & supplier

We serve Chemical Name:(1R)-1-(3-Fluoro-4-methylphenyl)-1-propanamine hydrochloride (1:1 ) CAS:1213012-56-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(1R)-1-(3-Fluoro-4-methylphenyl)-1-propanamine hydrochloride (1:1 )

Chemical Name:(1R)-1-(3-Fluoro-4-methylphenyl)-1-propanamine hydrochloride (1:1 )
CAS.NO:1213012-56-6
Synonyms:(1R)-1-(3-Fluoro-4-methylphenyl)-1-propanamine hydrochloride (1:1 )
Molecular Formula:C10H15ClFN
Molecular Weight:203.68400
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:26.02000
Exact Mass:203.08800
LogP:4.04620

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (1R)-1-(3-Fluoro-4-methylphenyl)-1-propanamine hydrochloride (1:1 ) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(1R)-1-(3-Fluoro-4-methylphenyl)-1-propanamine hydrochloride (1:1 ) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(1R)-1-(3-Fluoro-4-methylphenyl)-1-propanamine hydrochloride (1:1 ) Use and application,(1R)-1-(3-Fluoro-4-methylphenyl)-1-propanamine hydrochloride (1:1 ) technical grade,usp/ep/jp grade.


Related News: Importance of evaluating biocatalytic processes during development N-(4-(2-(4-fluorophenyl)cyclopropyl)thiophen-3-yl)-1-methyl-4-(trifluoromethyl)-1H-pyrrole-3-carboxamide manufacturers The client needed full development and product readiness with an extremely short supply of the API. In addition, the scale-up batch was small because of the low volume of product demands of their orphan drug. 4-[(3R,4R,1E)-3-(4-methoxybenzyloxy)-2,4-dimethylhexa-1,5-dienyl]-2-methyloxazole suppliers Grégoire Boutonnet, Chief Operating Officer of NOVA, said: “I am thrilled to be joining the NOVA team at this exciting period of growth as we launch the Jinkō platform towards wider adoption in the clinical trial development space. methoxycarbonyloxy-acetic acid-(4-chloro-anilide) vendor & factory.